glp 1 zayıflama hapı GLP-1 İlaçları Nedir? Yeni Nesil Zayıflama İlaçları: GLP-1

Never share tirzepatide pens with others, even if the needle has been changed, as this poses serious infection risks

GIP helps: Improve how your body uses insulin Reduce blood sugar spikes Shift your body away from fat storage When GLP-1 reduces hunger and GIP improves metabolic efficiency, weight loss becomes easier

Lunch: palm-sized protein (chicken, fish, tofu), large serving of vegetables, healthy fat (avocado, olive oil, nuts)

A week later, less so

doi: 10.1161/CIR.0000000000001052

Based on the research and clinical trials, here are the disease states and associated risk reductions with GLP-1 medications: Cardiovascular Disease: Major adverse cardiovascular events (MACE): 20-26% reduction Heart attack: ~20% reduction Stroke: ~20% reduction Cardiovascular death: ~15-20% reduction Heart Failure: Heart failure with preserved ejection fraction (HFpEF): Improved symptoms, exercise tolerance, and body composition Heart failure hospitalizations: Reduced (specific percentages vary by study) Kidney Disease: Progression to end-stage renal disease: 20-30% reduction Decline in eGFR: Slowed progression Type 2 Diabetes: Progression from prediabetes to diabetes: Reduced risk (specific percentage varies) Liver Disease: NAFLD/NASH improvement: Reduced liver fat and inflammation Liver enzyme normalization: Significant improvement in ALT/AST Obesity-Related Complications: Body weight reduction: 10-15% (semaglutide), 15-22% (tirzepatide) Visceral fat reduction: Substantial decrease Metabolic Syndrome Components: Blood pressure: 5-10 mmHg reduction in systolic BP Triglycerides: 20-30% reduction Insulin resistance: Significant improvement Cancer: (emerging data) Overall cancer risk: Potential reduction (10-20% suggested in some observational studies) Specific cancers linked to obesity/metabolic dysfunction: Reduced risk observed Neurodegeneration: (preliminary data) Alzheimers disease progression: Some trials are ongoing, but recent data have been unpromising